Guanidine-Containing Methacrylamide (Co)polymers via aRAFT: Toward a Cell Penetrating Peptide Mimic().

Guanidine-Containing Methacrylamide (Co)polymers via aRAFT: Toward a Cell Penetrating Peptide Mimic().
复制标题

DOI:
10.1021/mz200012p
复制
发表时间:
2012-01-17
期刊:
影响因子:
7.015
通讯作者:
McCormick CL
McCormick CL
中科院分区:
化学1区
文献类型:
--
作者:
Treat NJ;Smith D;Teng C;Flores JD;Abel BA;York AW;Huang F;McCormick CL

文献摘要

参考文献

被引文献

相似文献

本文报道了3-胍基丙基甲基丙烯酰胺(GPMA)的水相可逆加成-断裂链转移(aRAFT)聚合合成和控制自由基同链和嵌段共聚。制备了N-(2-羟丙基)甲基丙烯酰胺(HPMA)的均聚物和嵌段共聚物,以模拟细胞穿透肽(CPPs)和聚精氨酸(bbb6单位)的行为,这些行为已被证明可以穿过细胞膜。4-氰基-4-(乙基磺酰硫代羰基磺酰)戊酸(CEP)在缓冲液中的均聚反应具有准一级动力学,分子量随转化率呈线性增长。通过GPMA macroCTA的成功链延伸,得到GPMA37-b-GPMA61 (Mw/Mn =1.05),证明了“活”硫碳基硫ω端基的保留。合成了GPMA与非免疫原性、生物相容性HPMA的嵌段共聚物,产物为HPMA271-b-GPMA13 (Mw/Mn = 1.15)。值得注意的是,利用fitc标记的含gpma的共聚物,在4°C和37°C下与KB细胞孵生2.5 h后,通过荧光显微镜、共聚焦激光扫描显微镜和流式细胞术实验证实了细胞内摄取。观察到的细胞摄取设施和aRAFT聚合提供的结构控制表明,这些合成(co)聚合物作为靶向治疗药物递送载体的巨大潜力。
We report the synthesis and controlled radical homo- and block copolymerization of 3-guanidinopropyl methacrylamide (GPMA) utilizing aqueous reversible addition-fragmentation chain transfer (aRAFT) polymerization. The resulting homopolymer and block copolymer with N-(2-hydroxypropyl) methacrylamide (HPMA) were prepared to mimic the behavior of cell penetrating peptides (CPPs) and poly(arginine) (> 6 units) which have been shown to cross cell membranes. The homopolymerization mediated by 4-cyano-4-(ethylsulfanylthiocarbonylsulfanyl)pentanoic acid (CEP) in aqueous buffer exhibited pseudo-first-order kinetics and linear growth of molecular weight with conversion. Retention of the “living” thiocarbonylthio ω-end-group was demonstrated through successful chain extension of the GPMA macroCTA yielding GPMA37-b-GPMA61 (Mw/Mn =1.05). Block copolymers of GPMA with the non-immunogenic, biocompatible HPMA were synthesized yielding HPMA271-b-GPMA13 (Mw/Mn = 1.15). Notably, intracellular uptake was confirmed by fluorescence microscopy, confocal laser scanning microscopy, and flow cytometry experiments after 2.5 h incubation with KB cells at 4 °C and at 37 °C utilizing FITC-labeled, GPMA-containing copolymers. The observed facility of cellular uptake and the structural control afforded by aRAFT polymerization suggest significant potential for these synthetic (co)polymers as drug delivery vehicles in targeted therapies.
DOI: 10.1016/j.jconrel.2008.10.004
发表时间: 2009-02-10
期刊: Journal of controlled release : official journal of the Controlled Release Society
影响因子: --
作者:
Convertine AJ;Benoit DS;Duvall CL;Hoffman AS;Stayton PS
通讯作者: Stayton PS
DOI: 10.1016/0304-4165(78)90339-2
发表时间: 1978-01-01
期刊: BIOCHIMICA ET BIOPHYSICA ACTA
影响因子: --
作者:
DUNCAN, R;LLOYD, JB
通讯作者: LLOYD, JB
DOI: 10.1002/pola.24129
发表时间: 2010-08-01
影响因子: --
作者:
Min, Eun Hee;Ting, S. R. Simon;Stenzel, Martina H.
通讯作者: Stenzel, Martina H.
DOI: 10.1021/bc049864q
发表时间: 2004-11-01
影响因子: 4.7
作者:
Funhoff, AM;van Nostrum, CF;Hennink, WE
通讯作者: Hennink, WE
DOI: 10.1111/j.1582-4934.2007.00062.x
发表时间: 2007-07
影响因子: 5.3
作者:
Jones AT
通讯作者: Jones AT